Distilled from 200+ enterprise deployments. These are the principles that separate successful Claude programmes from stalled pilots.
Build a curated literature knowledge base before deployment — quality in, quality out.
This applies across biotech & genomics organisations of all sizes. Teams that follow this principle consistently report better adoption rates and faster ROI realisation.
Use Claude's 200K context to pass complete research histories when generating hypotheses.
This applies across biotech & genomics organisations of all sizes. Teams that follow this principle consistently report better adoption rates and faster ROI realisation.
Always have a PhD-level reviewer validate Claude outputs for scientific submissions.
This applies across biotech & genomics organisations of all sizes. Teams that follow this principle consistently report better adoption rates and faster ROI realisation.
Deploy in an air-gapped environment for proprietary compound data — IP protection is paramount.
This applies across biotech & genomics organisations of all sizes. Teams that follow this principle consistently report better adoption rates and faster ROI realisation.
Use Claude for grant writing — dramatically improves the breadth and quality of background sections.
This applies across biotech & genomics organisations of all sizes. Teams that follow this principle consistently report better adoption rates and faster ROI realisation.
Integrate with PubMed and your internal document management for comprehensive literature access.
This applies across biotech & genomics organisations of all sizes. Teams that follow this principle consistently report better adoption rates and faster ROI realisation.
Use Claude for patent claim drafting first drafts — significant time savings for patent attorneys.
This applies across biotech & genomics organisations of all sizes. Teams that follow this principle consistently report better adoption rates and faster ROI realisation.
Build target-specific knowledge bases for each programme — focused context improves output quality.
This applies across biotech & genomics organisations of all sizes. Teams that follow this principle consistently report better adoption rates and faster ROI realisation.
Track hypothesis-to-candidate ratio before and after deployment as your scientific ROI metric.
This applies across biotech & genomics organisations of all sizes. Teams that follow this principle consistently report better adoption rates and faster ROI realisation.
Use Claude for board and investor presentations — transforms data into compelling programme narratives.
This applies across biotech & genomics organisations of all sizes. Teams that follow this principle consistently report better adoption rates and faster ROI realisation.
❌ Deploying without a clear ROI measurement framework
❌ Skipping the change management and training programme
❌ Trying to automate safety-critical decisions without human review
❌ Going straight to customer-facing AI without internal pilot first
90-minute session. No obligation. Discover your highest-impact deployment opportunities in 30 days.
3,000+ enterprise leaders read it every week. Join them.